Advertisement

Topics

Nimbus Discovery, LLC Company Profile

15:23 EDT 24th September 2018 | BioPortfolio

Nimbus Discovery, a biotechnology company, harnesses cutting-edge computational technologies to uncover breakthroughs in small molecule pharmacology. Nimbus focuses on medically important and highly sought-after disease targets that have proven inaccessible to traditional industry approaches. Nimbus’ robust pre-clinical pipeline includes novel agents for the treatment of cancer, metabolic disease and inflammation. The company is organized as a constellation of small, nimble teams of experienced drug-hunters deployed across program-focused subsidiary companies. Each team is freed from conventional barriers to scientific success, chartered to create solutions, and geared for program asset deals with leading pharmaceutical companies. Founded in 2009, Nimbus partnered with Schrödinger to invent and apply a physics-based approach that establishes a new standard for rational drug design. Nimbus is backed by world-class life science investors, including Atlas Venture, SR One, Lilly Ventures and Bill Gates. For more information please visit www.nimbusdiscovery.com.


News Articles [323 Associated News Articles listed on BioPortfolio]

Rosana Kapeller Leaves Nimbus, Seeks “Executive Leadership Role”

Rosana Kapeller has resigned her position as chief scientific officer of Cambridge, MA, biotech company Nimbus Therapeutics. The company said in a news release that she is leaving to “explore an exe...

Nimbus raises $65mm through late-stage round

Nimbus Therapeutics (computational chemistry, structural biology, and ADMET drug discovery) raised $65mm through what appears to be its Series C round. All existing investors participated, including A...

Nimbus Hires Adrian Ray, a 15-Year Gilead Veteran, as New SVP

Nimbus Therapeutics of Cambridge, MA, has hired Adrian Ray as senior vice president of discovery biology as it advances its immunology and oncology pipeline. Ray comes from Gilead Sciences (NASDAQ: GI...

Nimbus Therapeutics raises $65m in new capital to expand discovery efforts

Nimbus Therapeutics has raised $65m in new capital to accelerate its pipeline progress and fuel its expansion into new high-value targets aimed at overlapping biological mechanisms in immunology, onco...

Nimbus Nabs $65M to Advance In-House Drug Discoveries to the Clinic

Nimbus Therapeutics’ drugs have already found new homes with larger companies that aim to develop them into potential treatments for autoimmune and liver diseases. Selling its discoveries was a goal...

Nimbus Therapeutics secures $65m to accelerate pipeline progress and expand discovery effort

Nimbus Therapeutics has raised $65m in new capital to accelerate its pipeline progress and fuel its expansion into new high-value targets aimed at overlapping biological mechanisms in immunology, onco...

Nimbus looks inward

A $65 million financing led by Atlas Venture will help Nimbus build its in-house pipeline, redefining its partnering strategy.

Nimbus Therapeutics Names Adrian Ray, Ph.D., as Senior Vice President of Discovery Biology

Nimbus Therapeutics, a biotechnology company applying deep computational chemistry expertise throughout drug discovery and development, today announced that Adrian Ray, Ph.D., has...

PubMed Articles [464 Associated PubMed Articles listed on BioPortfolio]

Translation of innovative chemistry into screening libraries: an exemplar partnership from the European Lead Factory.

The identification of high-quality starting points for drug discovery is an enduring challenge in medicinal chemistry. Yet, the chemical space explored in discovery programmes tends be limited by the ...

The continuing effect of the discovery of IgE by Kimishige Ishizaka.

Sadly, Kimi Ishizaka died on July 6, 2018. I would like to take the opportunity to consider his role in the discovery of IgE and the effect of that discovery. All of us owe an enormous debt to those w...

Filling the drug discovery gap: is high-content screening the missing link?

In recent years, questions about the sustainability of the current drug discovery process have triggered a revival of interest in phenotypic drug discovery approaches. This trend has clearly been ampl...

Nimbus: A design-driven analyses suite for amplicon based NGS data.

PCR-based DNA enrichment followed by massively parallel sequencing is a straightforward and cost effective method to sequence genes up to high depth. The full potential of amplicon based sequencing as...

Computational Toxicology and Drug Discovery.

The use of computational toxicology methods within drug discovery began in the early 2000s with applications such as predicting bacterial mutagenicity and hERG inhibition. The field has been continuou...

Clinical Trials [181 Associated Clinical Trials listed on BioPortfolio]

Sub-chronic Neurostimulation Delivered in the Middle Ear for Tinnitus Suppression

The objectives of this study are to evaluate the safety and efficacy of applying electrical stimulation on the Promontorium and the vicinity of the round window for the suppression of tinn...

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Companies [1107 Associated Companies listed on BioPortfolio]

Nimbus Discovery LLC

Nimbus Discovery is applying advances in computer-based drug discovery to develop new medicines against important drug targets and thereby unlock fundamental biological pathways. ...

Nimbus Therapeutics

Nimbus Therapeutics harnesses the power of computational chemistry to design breakthroughs for the treatment of substantial and underserved human diseases. The company’s focu...

Nimbus Discovery, LLC

Nimbus Discovery, a biotechnology company, harnesses cutting-edge computational technologies to uncover breakthroughs in small molecule pharmacology. Nimbus focuses on medically i...

NIMBUS Biotechnology GmbH

Welcome to NIMBUS Biotechnology! NIMBUS Biotechnology is an ADME focused Biotech company. Transil ADME Assays are innovative screening tools giving access to some of the most important ADME parameter...

Nimbus Therapeutics, LLC

Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pi...

More Information about "Nimbus Discovery, LLC" on BioPortfolio

We have published hundreds of Nimbus Discovery, LLC news stories on BioPortfolio along with dozens of Nimbus Discovery, LLC Clinical Trials and PubMed Articles about Nimbus Discovery, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nimbus Discovery, LLC Companies in our database. You can also find out about relevant Nimbus Discovery, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record